BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 23201157)

  • 1. A novel Aurora-A-mediated phosphorylation of p53 inhibits its interaction with MDM2.
    Hsueh KW; Fu SL; Chang CB; Chang YL; Lin CH
    Biochim Biophys Acta; 2013 Feb; 1834(2):508-15. PubMed ID: 23201157
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polo-like kinase-1 phosphorylates MDM2 at Ser260 and stimulates MDM2-mediated p53 turnover.
    Dias SS; Hogan C; Ochocka AM; Meek DW
    FEBS Lett; 2009 Nov; 583(22):3543-8. PubMed ID: 19833129
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phosphorylation by aurora kinase A induces Mdm2-mediated destabilization and inhibition of p53.
    Katayama H; Sasai K; Kawai H; Yuan ZM; Bondaruk J; Suzuki F; Fujii S; Arlinghaus RB; Czerniak BA; Sen S
    Nat Genet; 2004 Jan; 36(1):55-62. PubMed ID: 14702041
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HEY1 functions are regulated by its phosphorylation at Ser-68.
    López-Mateo I; Arruabarrena-Aristorena A; Artaza-Irigaray C; López JA; Calvo E; Belandia B
    Biosci Rep; 2016 Jul; 36(3):. PubMed ID: 27129302
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The MDM2 ubiquitination signal in the DNA-binding domain of p53 forms a docking site for calcium calmodulin kinase superfamily members.
    Craig AL; Chrystal JA; Fraser JA; Sphyris N; Lin Y; Harrison BJ; Scott MT; Dornreiter I; Hupp TR
    Mol Cell Biol; 2007 May; 27(9):3542-55. PubMed ID: 17339337
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aurora-A phosphorylates hnRNPK and disrupts its interaction with p53.
    Hsueh KW; Fu SL; Huang CY; Lin CH
    FEBS Lett; 2011 Sep; 585(17):2671-5. PubMed ID: 21821029
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aurora-A abrogation of p53 DNA binding and transactivation activity by phosphorylation of serine 215.
    Liu Q; Kaneko S; Yang L; Feldman RI; Nicosia SV; Chen J; Cheng JQ
    J Biol Chem; 2004 Dec; 279(50):52175-82. PubMed ID: 15469940
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Wip1 Phosphatase acts as a gatekeeper in the p53-Mdm2 autoregulatory loop.
    Lu X; Ma O; Nguyen TA; Jones SN; Oren M; Donehower LA
    Cancer Cell; 2007 Oct; 12(4):342-54. PubMed ID: 17936559
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Murine protein serine-threonine kinase 38 activates p53 function through Ser15 phosphorylation.
    Seong HA; Ha H
    J Biol Chem; 2012 Jun; 287(25):20797-810. PubMed ID: 22532570
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HIPK2 inhibits both MDM2 gene and protein by, respectively, p53-dependent and independent regulations.
    Di Stefano V; Mattiussi M; Sacchi A; D'Orazi G
    FEBS Lett; 2005 Oct; 579(25):5473-80. PubMed ID: 16212962
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The human vaccinia-related kinase 1 (VRK1) phosphorylates threonine-18 within the mdm-2 binding site of the p53 tumour suppressor protein.
    Lopez-Borges S; Lazo PA
    Oncogene; 2000 Jul; 19(32):3656-64. PubMed ID: 10951572
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel site of AKT-mediated phosphorylation in the human MDM2 onco-protein.
    Milne D; Kampanis P; Nicol S; Dias S; Campbell DG; Fuller-Pace F; Meek D
    FEBS Lett; 2004 Nov; 577(1-2):270-6. PubMed ID: 15527798
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ATM and Chk2-dependent phosphorylation of MDMX contribute to p53 activation after DNA damage.
    Chen L; Gilkes DM; Pan Y; Lane WS; Chen J
    EMBO J; 2005 Oct; 24(19):3411-22. PubMed ID: 16163388
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The carboxy-terminal serine 392 phosphorylation site of human p53 is not required for wild-type activities.
    Fiscella M; Zambrano N; Ullrich SJ; Unger T; Lin D; Cho B; Mercer WE; Anderson CW; Appella E
    Oncogene; 1994 Nov; 9(11):3249-57. PubMed ID: 7936649
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel p53 phosphorylation site within the MDM2 ubiquitination signal: I. phosphorylation at SER269 in vivo is linked to inactivation of p53 function.
    Fraser JA; Vojtesek B; Hupp TR
    J Biol Chem; 2010 Nov; 285(48):37762-72. PubMed ID: 20851891
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutation at Ser392 specifically sensitizes mutant p53H175 to mdm2-mediated degradation.
    Gillotin S; Yap D; Lu X
    Cell Cycle; 2010 Apr; 9(7):1390-8. PubMed ID: 20234175
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mdm2: p53's lifesaver?
    Shmueli A; Oren M
    Mol Cell; 2007 Mar; 25(6):794-6. PubMed ID: 17386256
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phage-peptide display identifies the interferon-responsive, death-activated protein kinase family as a novel modifier of MDM2 and p21WAF1.
    Burch LR; Scott M; Pohler E; Meek D; Hupp T
    J Mol Biol; 2004 Mar; 337(1):115-28. PubMed ID: 15001356
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HMG-CoA reductase inhibitors, statins, induce phosphorylation of Mdm2 and attenuate the p53 response to DNA damage.
    Pääjärvi G; Roudier E; Crisby M; Högberg J; Stenius U
    FASEB J; 2005 Mar; 19(3):476-8. PubMed ID: 15625077
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional significance of Aurora kinase A regulatory interactions with p53-ERα complex in human breast cancer cells.
    Katayama H; Sen S
    Horm Cancer; 2011 Apr; 2(2):117-24. PubMed ID: 21761334
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.